These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 23377327)

  • 1. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.
    Taylor MB; Yanaki JS; Draper DO; Shurtz JC; Coglianese M
    J Drugs Dermatol; 2013 Jan; 12(1):45-50. PubMed ID: 23377327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report.
    Lee GS
    J Cosmet Laser Ther; 2008 Dec; 10(4):234-6. PubMed ID: 18830869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma.
    Huh CH; Seo KI; Park JY; Lim JG; Eun HC; Park KC
    Dermatology; 2003; 206(4):316-20. PubMed ID: 12771472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma.
    Sobhi RM; Sobhi AM
    J Cosmet Dermatol; 2012 Mar; 11(1):65-71. PubMed ID: 22360337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
    Kauvar AN
    Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation.
    Grimes PE
    Cutis; 2004 Dec; 74(6):362-8. PubMed ID: 15663072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
    Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
    Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
    Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
    J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical treatments for melasma and postinflammatory hyperpigmentation.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation.
    Cook-Bolden FE; Hamilton SF
    Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo.
    Choi YK; Rho YK; Yoo KH; Lim YY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK; Kim DS
    Int J Dermatol; 2010 Feb; 49(2):218-26. PubMed ID: 20465650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
    Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
    Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperpigmentation-melasma with photodynamic therapy.
    Marcus L
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):9-11. PubMed ID: 16485875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural ingredients for darker skin types: growing options for hyperpigmentation.
    Alexis AF; Blackcloud P
    J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s123-7. PubMed ID: 24002160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of melasma with Pycnogenol.
    Ni Z; Mu Y; Gulati O
    Phytother Res; 2002 Sep; 16(6):567-71. PubMed ID: 12237816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy of products containing azelaic acid in melasma treatment.
    Mazurek K; Pierzchała E
    J Cosmet Dermatol; 2016 Sep; 15(3):269-82. PubMed ID: 27028014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.